Found: 7
Select item for more details and to access through your institution.
Correction to: Progressive multifocal leukoencephalopathy in rituximab-treated rheumatic diseases: a rare event.
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
Progressive multifocal leukoencephalopathy in rituximab-treated rheumatic diseases: a rare event.
- Published in:
- Journal of NeuroVirology, 2018, v. 24, n. 3, p. 323, doi. 10.1007/s13365-018-0615-7
- By:
- Publication type:
- Article
Long-Term Safety of Rituximab in Granulomatosis With Polyangiitis and in Microscopic Polyangiitis.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Rituximab pediatric drug development: Pharmacokinetic and pharmacodynamic modeling to inform regulatory approval for rituximab treatment in patients with granulomatosis with polyangiitis or microscopic polyangiitis.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 9, p. 2172, doi. 10.1111/cts.13351
- By:
- Publication type:
- Article
Evaluation of Serious Infection in Pediatric Patients with Low Immunoglobulin Levels Receiving Rituximab for Granulomatosis with Polyangiitis or Microscopic Polyangiitis.
- Published in:
- Rheumatology & Therapy, 2022, v. 9, n. 2, p. 721, doi. 10.1007/s40744-022-00433-0
- By:
- Publication type:
- Article
Risk of Malignancies in Patients with Rheumatoid Arthritis Treated with Rituximab: Analyses of Global Postmarketing Safety Data and Long-Term Clinical Trial Data.
- Published in:
- Rheumatology & Therapy, 2020, v. 7, n. 1, p. 121, doi. 10.1007/s40744-019-00183-6
- By:
- Publication type:
- Article
Phase IIa Global Study Evaluating Rituximab for the Treatment of Pediatric Patients With Granulomatosis With Polyangiitis or Microscopic Polyangiitis.
- Published in:
- Arthritis & Rheumatology, 2022, v. 74, n. 1, p. 124, doi. 10.1002/art.41901
- By:
- Publication type:
- Article